SLN124 is a GalNAc conjugated double stranded fully modified siRNA. Sodium chloride 0.9% w/v is used as Placebo
SLN124-001
Phase 1 small_molecule terminated
Quick answer
SLN124 is a GalNAc conjugated double stranded fully modified siRNA. Sodium chloride 0.9% w/v is used as Placebo for Non-transfusion-dependent Thalassemia is a Phase 1 program (small_molecule) at Silence Therapeutics plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Silence Therapeutics plc
- Indication
- Non-transfusion-dependent Thalassemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated